Prophylactic Vaccine against Malignant Melanoma
Malignant Melanoma is the most rapidly increasing cancer in white populations with a doubling of rates every 10 years. Göttinger inventors identified in a study with almost 100.000 subjects the Yellow Fever Vaccine (YFV) as a prophylactic vaccine against malignant melanoma.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Better magnets for green energy
Researchers use multicomponent alloys to make strong and ductile soft magnetic materials. Latest results now published in the journal Nature. Soft magnetic materials (SMMs) applied in electric engines transform energy…
Sound plus electrical body stimulation has potential to treat chronic pain
New technique could relieve pain for individuals with various chronic and neurological conditions. A University of Minnesota Twin Cities-led team has found that electrical stimulation of the body combined with…
Bioengineered cornea can restore sight to the blind and visually impaired
Bioengineered corneal tissue for minimally invasive vision restoration in advanced keratoconus in two clinical cohorts. Researchers and entrepreneurs have developed an implant made of collagen protein from pig’s skin, which…
